Phenotypic characteristics and protective efficacy of an attenuated Mycoplasma hyopneumoniae vaccine by aerosol administration

• Published in: Vaccine Vol. 40; no. 42; pp. 6074 - 6083
• Main Authors: Hao, Fei, Bai, Yun, Xie, Xing, Yuan, Ting, Wei, Yanna, Xiong, Qiyan, Gan, Yuan, Zhang, Lei, Zhang, Zhenzhen, Shao, Guoqing, Feng, Zhixin
• Format: Journal Article
• Language: English
• Published: Kidlington Elsevier Ltd 06.10.2022; Elsevier Limited
• Subjects: Aerosol vaccination; Aerosols; Animal husbandry; Antigens; Atomizing; Diameters; Experiments; Farms; Genomes; Glass substrates; Hogs; Immune response; Immune system; Immunization; Infections; Lung diseases; Mucosal immunity; Mycoplasma hyopneumoniae; Particle size; Pathogens; Phenotypic characteristics; Protective efficacy; Respiratory tract; Swine; Ultrasonic atomizer; Vaccines; United States > US; China; Protective efficacy; Ultrasonic atomizer; Phenotypic characteristics; Aerosol vaccination; Mycoplasma hyopneumoniae
• ISSN: 0264-410X; 1873-2518
• DOI: 10.1016/j.vaccine.2022.08.072

•An aerosol vaccine of Mhp could be nebulized by a ultrasonic atomizer.•The aerodynamic particle size of the Mhp aerosol vaccine was 2.98 ± 0.02.•The shape, size, and uniformity of collected aerosols are relatively stable.•The Mhp aerosol vaccine could induce good mucosal immunity.•The Mhp aerosol vaccine could provide protection against Mhp challenge. With the improvement of large-scale breeding in pig farms, conventional head-by-head immunization has disadvantages with low efficiency and high cost. Considering that most pathogens leading to pulmonary diseases circulate from the respiratory mucosa, immunization through the respiratory tract route has been a highly attractive vaccine delivery strategy. In this study, to develop an effective Mycoplasma hyopneumoniae (Mhp) aerosol vaccine, a customized ultrasonic atomizer was developed. The aerodynamic diameter, activity, and content of the Mhp aerosol vaccine were measured. In addition, piglets were immunized with the Mhp aerosol vaccine, and the immunity of the animal challenge protection test was evaluated. At the end of nebulization, the mass median aerodynamic diameters (MMAD) and geometric standard deviation (GSD) of the aerosol were 2.98 ± 0.02 μm and 1.51 ± 0.02, respectively. Moreover, 10 min after nebulization, the MMAD and GSD of the aerosol were 2.76 ± 0.02 μm and 1.51 ± 0.01, respectively, which were hardly changed. Compared with theoretical value, the actual titer of aerosol vaccines presented in 50% color changing unit (CCU50) after nebulization decreased 0.6. The shape, size, and uniformity of collected aerosols are relatively stable. The proportion of Mhp in aerosol produced by vaccine stock solution and 10 times diluted vaccine solution was 76.52% and 58.82%, respectively, and the average number of Mhp in a single aerosol was 3.06 and 1.51, respectively. In addition, the aerosol vaccine antigen particles could be transported to the lower respiratory tract, a local mucosal immune response was induced in piglets. The vaccine colonized the respiratory tract and significantly decline the lung lesion index after aerosol vaccination. In conclusion, an effective aerosol vaccine against Mhp infection was developed. And this is the first effective assessment for Mhp live vaccine with aerosolization against infection in piglets.